Recent Finacing
Recent Raise
Spiracur develops mechanically powered, single-use, ultraportable negative pressure wound therapy devices (SNaP, ciSNaP) that are battery-free, silent, 2.2-ounce wearable systems with FDA 510(k) and CE Mark.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors